Chemoenzymatic total synthesis of the antibiotic (-)-13-deoxytetrodecamycin using the Diels-Alderase TedJ.
Russell, S.J., Back, C.R., Perry, C., Cheung, K.A., Maschio, L., Charlton, S.N., Lees, N.R., Manzo-Ruiz, M., Hayes, M.A., van der Kamp, M.W., Race, P.R., Willis, C.L.(2025) Chem Sci 16: 16993-16999
- PubMed: 40880792 Search on PubMedSearch on PubMed Central
- DOI: https://doi.org/10.1039/d5sc05480j
- Primary Citation Related Structures: 
8R1R - PubMed Abstract: 
The tetrodecamycins are tetracyclic natural products that exhibit potent antimicrobial activity against a multitude of drug-resistant pathogens. These compounds are structurally distinguished by the presence of a tetronate ring and trans -decalin with six contiguous asymmetric centres united by a seven-membered oxygen heterocycle. Herein we describe the first total synthesis of the antibiotic (-)-13-deoxytetrodecamycin. Our strategy is predicated on an enantioselective [4 + 2]-cycloaddition catalysed by the FAD-dependent Diels-Alderase TedJ, forming the trans -decalin with concomitant creation of two rings and four contiguous stereocenters with exquisite selectivity under mild conditions. In complementary studies, in vitro enzyme assays, X-ray crystallography and computational modelling are used to provide molecular insights into the TedJ catalysed reaction. These studies illustrate the power of adopting a chemoenzymatic approach for the enantioselective synthesis of a target compound which would be difficult to achieve using non-biological methods and provide a practical demonstration of the use of Diels-Alder biocatalysts in total synthesis. This approach has potentially widespread value in the global challenge of discovery and development of new antibiotics.
- School of Chemistry, University of Bristol Cantock's Close Bristol BS8 1TS UK chris.willis@bristol.ac.uk.
Organizational Affiliation: 
















